SCHEMBL4852302

SCHEMBL4852302

CCCC(C)(Oc1ccc(N)cc1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 7/20 0.49
PPARG P37231 4/20 0.49
ADORA3 P0DMS8 1/20 0.46
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 3/20 0.44
LMNA P02545 2/20 0.44
CYP2C19 P33261 2/20 0.44
TSHR P16473 2/20 0.44
CYP2C9 P11712 1/20 0.44
PDE4D Q08499 1/20 0.44
MAPT P10636 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
ELANE P08246 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAOA P21397 1/20 0.41
MEN1 O00255 1/20 0.40
CYP2D6 P10635 1/20 0.40
KMT2A Q03164 1/20 0.40
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11548438 0.87 ADORA3 (0.48) PPARAPPARGADORA3CYP1A2CYP3A4
SCHEMBL5531801 0.85 ADORA3 (0.47) PPARAPPARGADORA3CYP1A2CYP3A4
SCHEMBL7253896 0.85 PPARA (0.49) PPARAPPARGADORA3ALDH1A1SMN1; SMN2
SCHEMBL82055 0.85 PPARG (0.53) PPARAPPARGADORA3CYP1A2CYP3A4
SCHEMBL8935937 0.85 PPARG (0.53) PPARAPPARGADORA3CYP1A2CYP3A4
SCHEMBL3102154 0.84 PPARA (0.64) PPARAPPARGADORA3CYP1A2CYP3A4
SCHEMBL16753083 0.84 ADORA3 (0.46) PPARAPPARGADORA3CYP1A2CYP3A4
SCHEMBL2560059 0.84 L3MBTL1 (0.50) PPARAPPARGADORA3CYP1A2CYP3A4
SCHEMBL2421443 0.82 TSHR (0.47) PPARAPPARGADORA3CYP3A4TSHR
SCHEMBL2557598 0.81 ADORA3 (0.44) PPARAPPARGADORA3CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7348334-B2 Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2008-03-25 US disclosed
US-20030013729-A1 New monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LTD. 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013729-A1 New monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them GPR119, FFAR1, FFAR3 PPARA 60/4885PPARG 86/4885ADORA3 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.